1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006;6:411-425.
2. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003;86:125-139.
3. Vennervald BJ, Kenty L, Butterworth AE, Kariuki CH, Kadzo H, Ireri E, Amaganga C, Kimani G, Mwatha J, Otedo A, Booth M, Ouma JH, Dunne DW. Detailed clinical and ultrasound examination of children and adolescents in a
Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis. Trop Med Int Health 2004;9:461-470.
4. Cheever AW, Andrade ZA. Pathological lesions associated with
Schistosoma mansoni infections in man. Trans R Soc Trop Med Hyg 1967;61:626-639.
6. McCullough FS. The distribution of
Schistosoma mansoni and
Schistosoma haematobium in East Africa. Trop Geogr Med 1972;24:199-207.
7. World Health Organization. Report of the WHO informal consultation on schistosomiasis in low transmission areas: control strategies and criteria for elimination. London, UK. 10-13 April 2000. WHO/CDS/CPE/SIP/SIP2001.1;
www.who.int/ctd. 2001
8. Kardorff R, Gabone RM, Mugashe C, Obinga D, Ramarokoto CE, Mahlert C, Spannbrucker N, Lang A, Gunzler V, Gryseels B, Ehrich JHH, Doehring E.
Schistosoma mansoni related morbidity in Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters. Trop Med Int Health 1997;2:230-239.
9. Malenganisho WL, Magnussen P, Friis H, Siza J, Kaatano G, Temu M, Vennervald BJ.
Schistosoma mansoni morbidity among adults in two villages along Lake Victoria shore in Mwanza, Tanzania. Trans R Soc Trop Med Hyg 2008;102:532-541.
10. Gabone RM, Lwambo JNS. Epidemiology of S. mansoni and geohelminthiasis in Bukoba town, Kagera Region, Tanzania. Quarterly Report of the National Institute for Medical Research, Mwanza Medical Research Centre, Tanzania. 1994, pp 7-11.
11. Kabatereine NB. Schistosoma mansoni in a fishing community on the shores of Lake Albert at Butiaba, Uganda: epidemiology, morbidity, re-infection patterns and impact of treatment. Ministry of Health Uganda, Faculty of Science, University of Copenhagen and Danish Bilharziasis Laboratory. Copenhagen, Denmark. 2000, pp 73-75.
12. Magendantz M. The biology of
Biomphalaria choanomphala and
Biomphalaria sudanica in relation to their role in the transmission of
Schistosoma mansoni in Lake Victoria at Mwanza. Bull World Health Organ 1972;47:331-342.
13. Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM. Ultrasound in Schistosomiasis. A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis Related Morbidity. World Health Organization. Geneva, Switzerland. TDR/STR/SCH/00.1. 2000.
14. Yazdanpanah Y, Thomas AK, Kardorff R, Talla I, Sow S, Niang M, Stelma FF, Decam C, Rogerie F, Gryseels B, Capron A, Doehring E. Organometric investigations of the spleen and liver by ultrasound in
Schistosoma mansoni endemic and non-endemic villages in Senegal. Am J Trop Med Hyg 1997;57:245-249.
15. Kaatano GM. Impact of three years praziquantel treatment and health education on intestinal schistosomiasis infection and related hepatosplenic morbidity in rural island community in Northern-Western, Tanzania. Thesis for MPH, University of Jerusalem; Israel: 2003.
16. Doumenge JP, Mott K, Cheung C, Villenave D, Chapuis O, Perrin M, Reaud-Thomas G. Atlas of the Global Distribution of Schistosomiasis. Bordeaux, France. Universite de Bordeaux. 1987.
17. King CH, Blanton RE, Muchiri EM, Ouma JH, Kariuki HC, Mungai P, Magak P, Kadzo H, Ireri E, Koech DK. Low heritable component of risk for infection intensity and infection-associated disease in urinary schistosomiasis among Wadigo village populations in Coast Province, Kenya. Am J Trop Med Hyg 2004;70:57-62.
18. Booth M, Vennervald BJ, Kabatereine NB. Demographic patterns of organ size and periportal fibrosis vary considerably between neighbouring communities in Uganda heavily exposed to
Schistosoma mansoni infection. Trans R Soc Trop Med Hyg 2004;98:128-136.
19. Guyatt H, Gryseels B, Smith T, Tanner M. Assessing the public health importance of Schistosoma mansoni in different endemic areas: attributable fraction estimates as an approach. Am J Trop Med Hyg 1994;53:660-667.
20. Boisier P, Ramarokoto CE, Ravoniarimbinina P, Rabarijaona L, Ravaoalimalala VE. Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity. Trop Med Int Health 2001;9:699-706.
21. Gabone RM, Mugashe CL, Malenganisho WLM, Asztely A, Senkoro KP, Nilsson LA, Ouchterlony O. Ultrasonic evaluation of hepatosplenic morbidity in population of Kome Islands. In Proceedings of the 11th NIMR Annual Joint Scientific Conference with a Seminar on Malaria Control Research. 22-25 February 1993; Arusha, Tanzania: 1993. 171-182.
22. El Scheich T, Hofer L, G, Kaatano G, Foya J, Odhiambo D, Igogote J, Lwambo N, Ekamp H, Karst K, Häussinger D, Richter J. Hepatosplenic morbidity due to
Schistosoma mansoni in schoolchildren on Ukerewe Island, Tanzania. Parasitol Res 2012;110:2515-2520.
23. Homeida M, Ahmed S, Dafalla A, Suliman S, ElTom T, Nash T, Bennet JL. Morbidity associated with
Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am J Trop Med Hyg 1988;39:196-201.
24. Engels D, Sinzinkayo E, Gryseels B. Day-to-day egg count fluctuation in
Schistosoma mansoni infection and its operational implications. Am J Trop Med Hyg 1996;54:319-324.